{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:23:09Z","timestamp":1790716989728,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s10620-005-1588-y","type":"journal-article","created":{"date-parts":[[2005,2,10]],"date-time":"2005-02-10T03:15:39Z","timestamp":1108005339000},"page":"235-240","source":"Crossref","is-referenced-by-count":47,"title":["Risk Factors for Thromboembolic Complications in Inflammatory Bowel Disease: The Role of Hyperhomocysteinaemia"],"prefix":"10.1007","volume":"50","author":[{"given":"Bas","family":"Oldenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas A. C.","family":"Van Tuyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"van der Griend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Fijnheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard P.","family":"van Berge Henegouwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archinte.1936.00170110025002","volume":"58","author":"JA Bargen","year":"1936","unstructured":"Bargen JA, Barker NW: Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 58:17?31, 1936","journal-title":"Arch Intern Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0025-6196(12)65200-8","volume":"61","author":"RW Talbot","year":"1986","unstructured":"Talbot RW, Heppell J, Dozois RR, et al.: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61:140?145, 1986","journal-title":"Mayo Clin Proc"},{"key":"CR3","first-page":"617","volume":"9","author":"KP Koenigs","year":"1987","unstructured":"Koenigs KP, McPhedran P, Spiro HM: Thrombosis in inflammatory bowel disease. J Clin Gastroenterol 9:617?621, 1987","journal-title":"J Clin Gastroenterol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0016-5085(98)70253-7","volume":"115","author":"HA Liebman","year":"1998","unstructured":"Liebman HA, Kashani N, Sutherland D, et al.: The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology 115:830?834, 1998","journal-title":"Gastroenterology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00042737-199810000-00002","volume":"10","author":"HH \u00d6ver","year":"1998","unstructured":"\u00d6ver HH, \u00dclgen S, Tuglular T, et al.: Thrombophilia and inflammatory bowel disease: Does factor V mutation have a role? Eur J Gastroenterol Hepatol 10:827?829, 1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1572-0241.2000.01683.x","volume":"95","author":"IE Koutroubakis","year":"2000","unstructured":"Koutroubakis IE, Sfiridaki A, Mouzas IA, Maladaki A, Kapsoritakis A, Roussomoustakaki M, Kouroumalis EA, Manousos ON: Resistence to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am J Gastroenterol 95:190?194, 2000","journal-title":"Am J Gastroenterol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00004836-199810000-00007","volume":"27","author":"NP Zauber","year":"1998","unstructured":"Zauber NP, Sabbath-Solitare M, Rajoria G, et al.: Factor V Leiden mutation is not increased in patients with inflammatory bowel disease. J Clin Gastroenterol 27:215?216, 1998","journal-title":"J Clin Gastroenterol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(95)92407-8","volume":"346","author":"IJ Perry","year":"1995","unstructured":"Perry IJ, Refsum H, Morris RW, et al.: Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men Lancet 346:1395?1398, 1995","journal-title":"Lancet"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/ije\/24.4.704","volume":"24","author":"E Arnesen","year":"1995","unstructured":"Arnesen E, Refsum H, B\u00f8naa KH, et al.: Serum total homocysteine and coronary heart disease. Int J Epid 24:704?709, 1995","journal-title":"Int J Epid"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199502023320502","volume":"332","author":"J Selhub","year":"1995","unstructured":"Selhub J, Jacques PF, Bostom AG, et al.: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332:286?291, 1995","journal-title":"N Engl J Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-0037-1615380","volume":"80","author":"M den Heijer","year":"1998","unstructured":"den Heijer M, Rosendaal FR, Blom HJ, et al.: Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 80:874?877, 1998","journal-title":"Thromb Haemost"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","volume":"277","author":"IM Graham","year":"1997","unstructured":"Graham IM, Daly LE, Refsum HM, et al.: Plasma homocysteine as a risk factor for vascular disease. JAMA 277:1775?1781, 1997","journal-title":"JAMA"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, et al.: A candidate genetic risk factor for vascular isease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111?113, 1995","journal-title":"Nat Genet"},{"key":"CR14","first-page":"542","volume":"80","author":"M Cattaneo","year":"1998","unstructured":"Cattaneo M, Vecchi M, Zighetti ML, et al.: High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb Haemost 80:542?545, 1998","journal-title":"Thromb Haemost"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/gut.45.3.389","volume":"45","author":"N Mahmud","year":"1999","unstructured":"Mahmud N, Molloy A, McPartlin J, et al.: Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 45:389?394, 1999","journal-title":"Gut"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1111\/j.1572-0241.2000.03193.x","volume":"95","author":"B Oldenburg","year":"2000","unstructured":"Oldenburg B, Fijnheer R, van der Griend R, et al.: Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol 95:2825?2830, 2000","journal-title":"Am J Gastroenterol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-2143(98)90027-0","volume":"132","author":"der van","year":"1998","unstructured":"van der Griend R, Haas FJLM, Duran M, et al.: Methionine loading test is necessary for detection of hyperhomocysteinemia. J Lab Clin Med 132:67?72, 1998","journal-title":"J Lab Clin Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","volume":"1","author":"RF Harvey","year":"1980","unstructured":"Harvey RF, Bradshaw JM: A simple index of Crohn?s disease activity. Lancet 1:514, 1980","journal-title":"Lancet"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0140-6736(90)91521-B","volume":"336","author":"S Lichtiger","year":"1990","unstructured":"Lichtiger S, Present DH: Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet 336:16?19, 1990","journal-title":"Lancet"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-4347(87)80438-3","volume":"422","author":"A Araki","year":"1987","unstructured":"Araki A, Sako Y: Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 422:43?52, 1987","journal-title":"J Chromatogr"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000205234","volume":"17","author":"A Clauss","year":"1957","unstructured":"Clauss A: Gerinnungs physiologische Schnell method zur bestimmung des fibrinogens. Acta Haematol 17:237?246, 1957","journal-title":"Acta Haematol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","volume":"369","author":"RM Bertina","year":"1994","unstructured":"Bertina RM, Koeleman BP, Koster T, et al.: Mutation in blood coagulation factor V associated with resistence to activated protein C. Nature 369:64?67, 1994","journal-title":"Nature"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0038-1650614","volume":"76","author":"R Fijnheer","year":"1996","unstructured":"Fijnheer R, Horbach DA, Donders RC, et al.: Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thromb Haemost 76:514?517, 1996","journal-title":"Thromb Haemost"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","volume":"88","author":"SR Poort","year":"1996","unstructured":"Poort SR, Rosendaal FR, Reitsma PH, et al.: A common genetic variation in the 3?-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698?3703, 1996","journal-title":"Blood"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(95)90008-X","volume":"345","author":"M den Heijer","year":"1995","unstructured":"den Heijer M, Blom HJ, Gerrits WBJ, et al.: Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet 345:882?885, 1995","journal-title":"Lancet"},{"key":"CR26","first-page":"1775","volume":"227","author":"IM Graham","year":"1997","unstructured":"Graham IM, Daly LE, Refsum HM, et al.: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 227:1775?1781, 1997","journal-title":"The European Concerted Action Project. JAMA"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.ATV.17.5.989","volume":"17","author":"P Verhoef","year":"1997","unstructured":"Verhoef P, Kok FJ, Kruyssen DACM, et al.: Plasma total homocysteine, B-vitamins and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 17:989?995, 1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","volume":"338","author":"GN Welch","year":"1998","unstructured":"Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 338:1042?1050, 1998","journal-title":"N Engl J Med"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00001721-200007000-00013","volume":"11","author":"A Papa","year":"2000","unstructured":"Papa A, De Stefano V, Gasbarrini A, et al.: Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease. Blood Coagul Fibrinolysis 11:499?503, 2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/00042737-199911000-00018","volume":"11","author":"N Haslam","year":"1999","unstructured":"Haslam N, Standen GR, Probert CS: An investigation of the association ofthe factor V Leiden mutation and inflammatory bowel disease. Eur J Gastroenterol Hepatol 11:1289?1291, 1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"CR31","first-page":"399","volume":"336","author":"P Simioni","year":"1997","unstructured":"Simioni P, Pranoni P, Lensing AWA, et al.: The risk of recurrent venous thromboembolism in patients with an Arg506 ? Gln mutation in the gene for factor V. N Engl J Med 336:399?403, 1997","journal-title":"J Med"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1023\/A:1005541028045","volume":"45","author":"M Vecchi","year":"2000","unstructured":"Vecchi M, Sacchi E, Saibeni S, et al.: Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci 45:1465?1469, 2000","journal-title":"Dig Dis Sci"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/00042737-199710000-00008","volume":"9","author":"G Novacek","year":"1997","unstructured":"Novacek G, Kapiotis S, Moser G, et al.: No evidence of activated blood coagulation in Crohn?s disease. Eur J Gastroenterol Hepatol 9:963?967, 1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/gut.30.2.188","volume":"30","author":"E De Jong","year":"1989","unstructured":"De Jong E, Porte RJ, Knot EAR, et al.: Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces. Gut 30:188?194, 1989","journal-title":"Gut"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0049-3848(96)00060-6","volume":"82","author":"A Chirantini","year":"1996","unstructured":"Chirantini A, Valanzano R, Liotta AA, et al.: Hemostatic abnormalities in inflammatory bowel disease. Thromb Res 82:137?146, 1996","journal-title":"Thromb Res"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1023\/A:1026602803622","volume":"43","author":"IE Koutroubakis","year":"1998","unstructured":"Koutroubakis IE, Petinaki E, Anagnostopoulou E, et al.: Anti-cardiolipin and anti-?2-glycoprotein I antibodies in patients with inflammatory bowel disease. Dig Dis Sci 43:2507?2512, 1998","journal-title":"Dig Dis Sci"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1572-0241.2003.07160.x","volume":"98","author":"S Saibeni","year":"2003","unstructured":"Saibeni S, Cattaneo M, Vecchi M, et al. Low vitamin B6 levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol 98:112?117, 2003","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-1588-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-1588-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-1588-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T18:19:19Z","timestamp":1586110759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-1588-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["1588"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-1588-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}